Blood 132(Suppl1), 2018
A recent 2025 study of more than 6,000 psoriasis patients with diabetes or obesity over a 2-year period, including 3,048 who were treated with GLP-1RAs and 3,048 who received other anti-diabetic or anti-obesity drugs, found that psoriasis patients treated with GLP-1RAs had a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications
Context-dependent cytoprotection-associated profile: BPC-157-associated findings are most often reported in experimental models involving tissue injury, stress, vascular disturbance, or repair-associated endpoints rather than in basal, uninjured systems
The Glutathione-Sleep Cycle Interestingly, the relationship works both ways
We are thus left with poorly studied experimental drugs referred to as peptides, although some are not, sold for research use only, though clearly meant for human consumption, to gain a wide array of physical benefits that are unlikely to manifest
EMA EPAR for semaglutide) How Incretin Medications Affect Appetite and Satiety Incretin-based medications work by mimicking or enhancing the natural effects of incretin hormones, and one of their most notable effects is the promotion of satietythe feeling of fullness after eating
